🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/01/2002 | 62,69 | 63,41 | 59,14 | 59,33 | -5,37% | 6,81% | 51.082 |
| 17/01/2002 | 61,95 | 63,44 | 59,96 | 62,69 | +1,82% | 5,62% | 63.185 |
| 16/01/2002 | 61,98 | 64,79 | 61,57 | 61,57 | -2,26% | 5,19% | 72.375 |
| 15/01/2002 | 61,68 | 63,63 | 61,53 | 62,99 | +1,20% | 3,40% | 83.249 |
| 14/01/2002 | 66,89 | 67,00 | 62,25 | 62,25 | -6,83% | 7,11% | 76.971 |
| 11/01/2002 | 67,94 | 68,87 | 66,14 | 66,81 | -1,60% | 4,02% | 36.388 |
| 10/01/2002 | 67,52 | 68,80 | 66,44 | 67,90 | +0,55% | 3,49% | 58.296 |
| 09/01/2002 | 65,35 | 69,02 | 65,32 | 67,52 | +3,32% | 5,67% | 103.768 |
| 08/01/2002 | 65,84 | 66,10 | 63,97 | 65,35 | -0,11% | 3,24% | 84.264 |
| 07/01/2002 | 66,06 | 66,81 | 65,13 | 65,43 | -0,34% | 2,55% | 116.298 |
| 04/01/2002 | 66,03 | 66,03 | 62,40 | 65,65 | -0,06% | 5,50% | 98.878 |
| 03/01/2002 | 63,63 | 67,19 | 63,59 | 65,69 | +2,93% | 5,65% | 67.914 |
| 02/01/2002 | 67,04 | 67,34 | 62,21 | 63,82 | -4,75% | 7,65% | 83.703 |
| 31/12/2001 | 68,12 | 69,81 | 64,01 | 67,00 | -1,05% | 8,52% | 140.610 |
| 28/12/2001 | 68,57 | 70,70 | 66,85 | 67,71 | +0,67% | 5,62% | 140.957 |
| 27/12/2001 | 71,12 | 71,30 | 67,26 | 67,26 | -5,42% | 5,68% | 82.742 |
| 26/12/2001 | 69,73 | 71,49 | 68,31 | 71,12 | +1,06% | 4,56% | 72.456 |
| 24/12/2001 | 66,92 | 70,93 | 66,81 | 70,37 | +2,29% | 6,15% | 36.816 |
| 21/12/2001 | 67,30 | 69,25 | 67,00 | 68,80 | +1,83% | 3,34% | 129.629 |
| 20/12/2001 | 67,37 | 67,75 | 66,44 | 67,56 | -0,28% | 1,94% | 77.024 |
| 19/12/2001 | 67,52 | 68,68 | 66,06 | 67,75 | -1,36% | 3,88% | 78.494 |
| 18/12/2001 | 65,65 | 68,91 | 65,61 | 68,68 | +4,26% | 5,02% | 134.198 |
| 17/12/2001 | 60,37 | 67,00 | 60,37 | 65,88 | +7,32% | 10,97% | 105.264 |
| 14/12/2001 | 62,13 | 62,47 | 58,69 | 61,38 | +0,00% | 6,08% | 169.223 |
| 13/12/2001 | 61,38 | 64,57 | 60,41 | 61,38 | -0,67% | 6,77% | 140.904 |
| 12/12/2001 | 64,64 | 64,94 | 61,38 | 61,80 | -5,60% | 5,50% | 207.829 |
| 11/12/2001 | 67,79 | 68,31 | 64,34 | 65,46 | -1,85% | 5,85% | 200.322 |
| 10/12/2001 | 65,50 | 68,68 | 64,57 | 66,70 | +0,56% | 6,29% | 255.919 |
| 07/12/2001 | 66,85 | 66,96 | 64,01 | 66,33 | -1,01% | 4,42% | 130.190 |
| 06/12/2001 | 63,63 | 67,00 | 63,41 | 67,00 | +4,43% | 5,65% | 157.655 |